APA (7th ed.) Citation

T, P., J, B., C, C., J, K., I, E., H, G., . . . C, S. (2024). Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis. Cell reports. Medicine, 5(7), 101620. https://doi.org/10.1016/j.xcrm.2024.101620

Chicago Style (17th ed.) Citation

T, Poch, et al. "Intergenic Risk Variant Rs56258221 Skews the Fate of Naive CD4+ T cells via MiR4464-BACH2 Interplay in Primary Sclerosing Cholangitis." Cell Reports. Medicine 5, no. 7 (2024): 101620. https://doi.org/10.1016/j.xcrm.2024.101620.

MLA (9th ed.) Citation

T, Poch, et al. "Intergenic Risk Variant Rs56258221 Skews the Fate of Naive CD4+ T cells via MiR4464-BACH2 Interplay in Primary Sclerosing Cholangitis." Cell Reports. Medicine, vol. 5, no. 7, 2024, p. 101620, https://doi.org/10.1016/j.xcrm.2024.101620.